Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Article in Rheumatology (January 2021)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Article in JAMA Neurology (July 2015)
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
Article in Annals of the Rheumatic Diseases (June 2015)